Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
about
Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomasChildren's Oncology Group's 2013 blueprint for research: renal tumorsTargeted therapeutic strategies for the management of renal cell carcinomaDiagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese populationMiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)]PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressivenessCombination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methodsNext-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.Xp11.2 translocation renal cell carcinomas in young adultsMolecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersClinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studiesCharacterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant articleNon-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.Sunitinib malate for the treatment of renal cell carcinoma.Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features.Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway.Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.A case of metastatic Xp11.2 translocation renal cell carcinoma successfully managed by cytoreductive nephrectomy followed by axitinib therapyRapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report.Radiologic-pathologic correlation of renal cell carcinoma associated with Xp11.2 translocation.Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis.Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature.
P2860
Q26752945-E95D21F7-D418-4426-8D62-115C936009B6Q27000449-14619126-0EBF-4EFC-905D-BEC8F259EB52Q27013846-15956449-0BA4-4ED0-9EB1-E9893F18DDEBQ31046172-E6790054-47AA-49D8-8F4B-5126A17FC9FFQ33655468-EA70285B-5ACE-4905-BE89-635ADC1632AFQ33704636-96887D4A-0266-42B4-A6E0-9A474045E2B8Q33761537-45150EAE-8114-4B97-A22F-14D249DBEC8BQ34206517-27E9E69B-9A60-488C-B75F-9D22C11FB1AFQ34206531-FB02AC42-2664-4D1C-A29C-799693E93F4FQ35678902-E82B1E86-3942-46A2-BF83-B0961B56BB98Q36001179-2BF79AFA-3C8A-45E8-A8E4-963A4BC46559Q36073126-84241CD9-7579-4BB2-8498-C299C6B4BD4AQ36105584-1D23D04C-6920-4F5C-BA55-F4D7B4811E1DQ36151526-39F81D03-4F4C-4CE0-A784-056DF3F4B296Q36182819-01397AF4-41E3-431B-BE67-BEA10423BE0AQ36205571-0482385A-B8BB-440F-9C18-7ABFEC4759D4Q37114357-81B4C4D8-FDDA-41F7-939A-0B5B1F68DFB1Q37836508-5C34405F-66A7-4CEE-BD1D-E62021A6DC48Q38011201-B7A89321-412E-45D9-BA5E-BC1C40B4ACDCQ38067125-68C3A628-4E9D-4990-8AE4-78DA512F7775Q38546367-F7A0D7ED-C872-48EE-A583-B642D107C758Q38697205-BB9BBBE9-B814-4875-AA77-29CB8C7163EFQ39012781-26F4BBA6-6DBF-4B1E-996C-0068E7A5547FQ39505003-E3487027-8997-4060-9870-BCFA4FCF1A9AQ41971524-A15B58E2-BD57-4CD9-9720-17D75071A352Q42249741-683FBD22-2D36-4F12-B229-D9728AECB627Q45867795-98A72022-0DD4-42A2-B6D1-A0620651AEA9Q47965589-9CA39C0F-A1F6-493E-93A9-E89E7E074C89Q52640027-76154115-2E71-4E03-ADD7-F63DE4530981Q55515293-62CC9DF8-80E1-4332-980A-9E1F64E8A858
P2860
Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... location renal cell carcinoma.
@ast
Vascular endothelial growth fa ...... location renal cell carcinoma.
@en
type
label
Vascular endothelial growth fa ...... location renal cell carcinoma.
@ast
Vascular endothelial growth fa ...... location renal cell carcinoma.
@en
prefLabel
Vascular endothelial growth fa ...... location renal cell carcinoma.
@ast
Vascular endothelial growth fa ...... location renal cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Vascular endothelial growth fa ...... location renal cell carcinoma.
@en
P2093
Daniel Y C Heng
David F McDermott
Eric Jonasch
Michelle S Hirsch
Nizar M Tannir
Paola Dal Cin
Pheroze Tamboli
Toni K Choueiri
Ulka Vaishampayan
P2860
P304
P356
10.1002/CNCR.25512
P407
P577
2010-11-01T00:00:00Z